CATX position history
The shares of Perspective Therapeutics (CATX) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 2,369,000 shares, $10M, 1.3% of portfolio, New
- 2026 Q1: 4,675,000 shares, $19M, 2.6% of portfolio, Add +97.3%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|